Gaede P., Vedel P., Larsen N., Jensen GV, Parving HH, Pedersen O.Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2008;358:580-591.
2.
Howard BV, Roman MJ, Devereux RB, et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA. 2008;299:1678-1689.
3.
Escobar C., Barrios V., Calderón A., et al. Diabetes mellitus in hypertensive population attended in primary care in Spain. Blood pressure and lipid control rates. Rev Clin Esp.2007;207:221-227.
4.
Vaccaro O., Boemi M., Cavalot F., et al. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis . 2008;198:396-402.
5.
Martin OJ, Wu WC, Taveira TH, Eaton CB, Sharma SCMultidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes: a pilot study. Diabetes Educ. 2007;33:118-127.
6.
Steg PG, Lopez-Sendon J., Lopez de Sa E., et al. External validity of clinical trials in acute myocardial infarction . Arch Intern Med. 2007;167:68-73.
